Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure - A controlled clinical trial

Journal of Hepatology

Volumn 41, Issue 1, 2004, Pages 89-96

  Bhatia, Vikram ^a   Batra, Yogesh ^a   Acharya, Subrat Kumar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Acute liver failure; Phenytoin; Seizure

Indexed keywords

PHENYTOIN;

ADOLESCENT; ADULT; ARTICLE; ARTIFICIAL VENTILATION; BRAIN EDEMA; BRAIN PROTECTION; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG EFFECT; FEMALE; HUMAN; HYPERAMMONEMIA; LIVER FAILURE; MALE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SEIZURE SUSCEPTIBILITY; SURVIVAL RATE; TREATMENT FAILURE;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; BRAIN EDEMA; EPILEPSY; FEMALE; HUMANS; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; PHENYTOIN; PREGNANCY; PROGNOSIS; RESPIRATION, ARTIFICIAL; SURVIVAL RATE;

EID: 3442884202     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.03.017     Document Type: Article

References (23)

1. Flannery D.B., Hsia Y.E., Wolf B. Current status of hyperammonia syndromes. Hepatology. 2:1982;495-506
2. Strauss G.I., Knudson G.M., Kondrup J., Moller K., Larsen F.S. Cerebral metabolism of ammonia and amino acids in patients with fulminant hepatic failure. Gastroenterology. 121:2001;1109-1119
3. Clemmensen J.O., Larsen F.S., Kondrup J., Hansen B.A., Ott P. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology. 29:1999;648-653
4. Blei A.T. Medical therapy of brain edema in fulminant hepatic failure. Hepatology. 32:2000;666-669
5. Ellis A.T., Wendon J.A., William R. Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: a controlled clinical trial. Hepatology. 32:2000;536-541
6. Tandon B.N., Bernauau J., O'Grady J., Gupta S.D., Krish R.E., Liaw Y.F., et al. Recommendations of the International Association for the study of the liver subcommittee on nomenclature of acute and subacute liver failure. J Gastroenterol Hepatol. 14:1999;403-404
7. Acharya S.K., Dasarathy S., Kumer T.L., Sushma S., Uma Prasanna K.S., Tandon A., et al. Fulminant hepatitis in a tropical population: clinical course, cause and early predictors of outcome. Hepatology. 23:1996;1448-1455
8. Riegler J.L., Lake J.R. Fulminant hepatic failure. Med Clin North Am. 77:(1057):1993;83
9. Ede R.J., Williams R. Hepatic encephalopathy and cerebral edema. Semin Liver Dis. 6:1986;107-118
10. Nanda S.K., Yalchinkaya K., Panigrahi A.K., Acharya S.K., Jameel S., Panda S.K. Etiological role of hepatitis E virus in sporadic fulminant hepatitis. J Med Virol. 42:1994;133-137
11. Jameel S., Durgapal H., Habibullah C.M., Khuroo M.S., Panda S.K. Enteric non A, non B hepatitis: epidemics, animal transmission, and hepatitis E virus detection by the polymerase chain reaction. J Med Virol. 37:1992;263-270
12. Cha T., Kolberg J., Irvene B., Stempien M., Beall E., Yano M., et al. Use of a signature nucleotide sequence of hepatitis C virus for detection of viral RNA in human serum and plasma. J Clin Microbiol. 29:1991;2528-2534
13. Grondahl T.O., Langmoen I.A. Epileptogenic effect of antibiotic drugs. J Neurosurg. 78:1993;938-943
14. De Sarro A., Ammendola D., Zappala M., Grasso S., De Sarro G.B. Relationship between structure and convulsant properties of some beta lactam antibiotics following intracerebroventricular microinjection in rats. Antimicrob Agents Chemother. 39:1995;232-237
15. Shimokawa M., Yamamoto K., Kawakami J., Sawada Y., Iga T. Effect of hepatic or renal dysfunction on neurotoxic convulsion induced by ranitidine in mice. Pharm Res. 11:1994;1519-1523
16. Gazzard B.G., Portmann B., Murray-Lyon I.M., Williams R. Cause of death in fulminant hepatic failure and relationship to quantitative histological assessment of parenchymal damage. Q J Med. 176:1975;615-626
17. Schiodt F.V., Bondesen S., Petersen I., Ott P., Tygstrup N. Admission levels of serum Gc-globulin: predictive value in fulminant hepatic failure. Hepatology. 23:1996;713-718
18. Papaevangelou G., Tassopoulos N., Roumeliotou-Karnayannis A., Richardson C. Etiology of fulminant viral hepatitis in Greece. Hepatology. 6:1986;648-665
19. Bernuau J., Goudeau A., Poynard T., Dubios F., Lesage G., Yvonnet B., et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology. 6:1986;648-665
20. Gimson A.E.S., O'Grady J., Ede R.J., Portmann B., Williams R. Late onset hepatic failure: clinical, serological and histological features. Hepatology. 6:1986;288-294
21. Rakela J. Etiology and prognosis in fulminant hepatitis. Acute hepatic failure study group. Gastroenterology. 77:1979;A33
22. Williams R., Riordan J.R. Fulminant hepatic failure. Schiff E.R., Sorrel M.F., Maddrey W.C. Diseases of the liver. 9th ed :2003;941-970 Lippincott, Philadelphia, PA
23. Yee H.F., Lidofsky S.D. Acute liver failure. Feldman M., Friedman L.S., Sleisenger M.H. Gastrointestinal and liver disease. 7th ed :2002;1567-1576 Saunders, London